Introducing Pathogen Reduction Technology in Poland: A Cost-Utility Analysis

Introducing Pathogen Reduction Technology in Poland: A Cost-Utility Analysis.

BACKGROUND Mirasol® pathogen reduction technology (PRT) uses UV light and riboflavin to chemically inactivate pathogens and white blood cells in blood components. In the EU, Mirasol PRT is CE-marked for both plasma and platelet treatment. In Poland, the decision to introduce PRT treatment of the national supply of fresh frozen plasma has spurred interest in evaluating the cost-effectiveness of ...

Teriparatide in the Treatment of Severe Postmenopausal Osteoporosis: A Cost-Utility Analysis in Iran

Background: Teriparatide is a new agent serves as a treatment of choice for severe post-menopausal osteoporotic patients who are at a high risk of fracture or have failed or been intolerant of previous osteoporosis therapy. The objective of this study is estimating the cost-utility of Teriparatide compared with no treatment from health system perspective in Iran. Method: A microsimulation...

Teriparatide in the Treatment of Severe Postmenopausal Osteoporosis: A Cost-Utility Analysis in Iran

Background: Teriparatide is a new agent serves as a treatment of choice for severe post-menopausal osteoporotic patients who are at a high risk of fracture or have failed or been intolerant of previous osteoporosis therapy. The objective of this study is estimating the cost-utility of Teriparatide compared with no treatment from health system perspective in Iran. Method: A microsimulation...

A cost–utility analysis

Neurology S. Claiborne Johnston, Daryl R. Gress and James G. Kahn Which unruptured cerebral aneurysms should be treated?: A cost–utility analysis This information is current as of January 25, 2006 http://www.neurology.org/cgi/content/full/52/9/1806 located on the World Wide Web at: The online version of this article, along with updated information and services, is Print ISSN: 0028-3878. Online ...

Pathogen Reduction of Plasma